During the past decade, Centre Hospitalier Uni Ire; Service Des Maladies Du Sang conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Uni Ire; Service Des Maladies Du Sang" are "Leukemia, Myeloid, Acute" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Centre Hospitalier Uni Ire; Service Des Maladies Du Sang" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Uni Ire; Service Des Maladies Du Sang" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chemotherapy (Induction Period)" (1 trials), "Cytarabine" (1 trials), "Idasanutlin" (1 trials), "Placebo" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Uni Ire; Service Des Maladies Du Sang" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hospitalier Uni Ire; Service Des Maladies Du Sang". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre Hospitalier Uni Ire; Service Des Maladies Du Sang, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Uni Ire; Service Des Maladies Du Sang, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".